AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Business, Spoken
From What's New: A Life-Extension Drug for Big Dogs Is Getting Closer to Reality
May 29, 2024
A San Francisco biotech company is developing a life-extension drug for large dog breeds, aiming to increase their longevity and well-being. The drug has received positive feedback from the FDA and targets a hormone linked to dog size. The podcast explores genetic factors in canine longevity, including breed-specific versions and the discovery of the ERBB-4 gene, with potential impacts for human health and ethical considerations.
05:48
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Loyal biotech company is developing a life extension drug for big dogs targeting hormone IGF-1.
- Genetic studies on dog longevity may offer insights into human health advancements and life extension research.
Deep dives
Developing Lifespan-Extending Drug for Large Dogs
A San Francisco biotech company, Loyal, is working on an experimental drug aimed at extending the lifespan and enhancing the quality of life for large and giant dog breeds. The drug targets a hormone called IGF-1, linked to dog size and lifespan. While the FDA is optimistic about the drug's potential effectiveness, further trials are required to assess its impact on lifespan.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode